Shandong Aishi Biotechnology
Retatrutide
Finnrick tested 16 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Shandong Aishi Biotechnology between 24 Oct 2025 and 1 Mar 2026. Test scores average below 4 or some scores below 3, and at least 6 tests, warrant a confident Finnrick Rating of E (Bad).
Finnrick Rating™
Shandong Aishi Biotechnology
Retatrutide
Tested 16 Samples
Last test 1 Mar 2026
Take Action
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Retatrutide tests from top-rated vendors:
All Retatrutide tests from Shandong Aishi Biotechnology
Samples are tested in commercial labs
Tests Count
16
Scores
AVGMINMAX
Last
1 Mar 2026
First
24 Oct 2025
| Quantity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Endotoxins | Batch ID | Container | Tested At | Sent By |
| 1 Mar 2026 | View | 10mg | 9.8mg | -2.0% | 99.70% | n/a | Yellow Cap | No Label / Silver Crimp / Yellow Cap | Lab G | Public | |
| 22 Feb 2026 | View | 20mg | 20.6mg | +3.0% | 99.90% | n/a | 11Sept25-SS64 | White Label / Silver Crimp / Black Cap | Lab E | Public | |
| 16 Feb 2026 | View | 10mg | 10.8mg | +8.0% | 99.90% | below LOQ | RT10SD202601 | No Label / Silver Crimp / Yellow Cap | Lab E | Public | |
| 16 Feb 2026 | View | 10mg | 2.81mg | -71.9% | 96.82% | n/a | (no batch ID) | No Label / Silver Crimp / Yellow Cap | Lab E | Public | |
| 4 Feb 2026 | View | 10mg | 10mg | 99.70% | n/a | Yellow cap | No Label / Silver Crimp / Yellow Cap | Lab G | Public | ||
| 29 Jan 2026 | View | 10mg | 10.9mg | +9.0% | 98.85% | n/a | (no batch ID) | No Label / Silver Crimp / Yellow Cap | Lab E | Public | |
| 29 Jan 2026 | View | 36mg | 37.3mg | +3.6% | 99.53% | n/a | September 16, 2025 | No Label / Silver Crimp / Blue Cap | Lab E | Public | |
| 22 Jan 2026 | View | 10mg | 10mg | 99.80% | n/a | AS251206 | No Label / Silver Crimp / Yellow Cap | Lab G | Public | ||
| 15 Jan 2026 | View | 10mg | 12.2mg | +22.0% | 99.80% | n/a | (no batch ID) | White Label / Silver Crimp / Yellow Cap | Lab G | Public | |
| 29 Dec 2025 | View | 10mg | 0.5mg | -95.0% | 73.18% | n/a | (no batch ID) | No Label / Silver Crimp / Yellow Cap | Lab E | Public | |
| 18 Dec 2025 | View | 30mg | 34.1mg | +13.7% | 99.80% | n/a | (no batch ID) | Green Label / Silver Crimp / Blue Cap | Lab G | Public | |
| 16 Dec 2025 | View | 20mg | 17.9mg | -10.5% | 99.70% | n/a | (no batch ID) | No Label / Silver Crimp / Pink Cap | Lab G | Public | |
| 25 Nov 2025 | View | 10mg | 10.4mg | +4.0% | 99.95% | n/a | Sep 15, 2025 | No Label / Silver Crimp / Yellow Cap | Lab E | Public | |
| 4 Nov 2025 | View | 10mg | 11.3mg | +13.0% | 99.60% | n/a | (no batch ID) | No Label / Silver Crimp / White Cap | Lab G | Public | |
| 29 Oct 2025 | View | 5mg | 4.78mg | -4.4% | 99.95% | n/a | (no batch ID) | No Label / Silver Crimp / Blue Cap | Lab E | Public | |
| 24 Oct 2025 | View | 20mg | 21.2mg | +6.0% | 99.70% | n/a | Sept 19, 2025 | No Label / Silver Crimp / Blue Cap | Lab G | Public | |